TOMI Environmental Solutions, Inc. (TOMZ) Q3 2025 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: Q3 2025 revenue was $2 million, a 95% sequential increase from Q2 2025 but a 24% decline compared to $2.5 million in Q3 2024. This decline was attributed to a timing reduction in IronHP service sales from a key customer.

Recurring Revenue: BIT solution sales increased by 21% year-to-date.

Gross Profit Margin: Remained strong at 61%, consistent with the previous year.

Operating Loss: Approximately $320,000, down from an operating income of $149,000 in Q3 2024.

Net Loss: Approximately $450,000 or $0.02 per share, compared to a net income of $58,000 in the same period last year.

Backlog: Sales order backlog was $900,000 at quarter-end, increasing to $1.3 million by October 31, with $3 million in pending contracts expected to close by year-end.

2Strategic Updates and Business Highlights

Growth in Equipment Sales: Increased capital purchases of mobile equipment from service provider partners, indicating growing customer engagement.

Market Expansion: The FDA's broadened approval of hydrogen peroxide usage opens new markets in food processing and agriculture, enhancing TOMI's competitive positioning.

Innovation and Partnerships: Continued investments in R&D and customer success, with a focus on automation and biosecurity advancements. Partnerships with major pharmaceutical companies and academic institutions are expanding TOMI's reach.

New Initiatives: Launched the SteraMist Pro Certified program to enhance customer training and implementation.

3Forward Guidance and Outlook

TOMI anticipates continued growth in BIT solution sales and capital equipment sales, with a focus on expanding its customer base and enhancing service offerings.

The company is optimistic about achieving growth objectives in Q4 2025 and into 2026, driven by a robust sales pipeline exceeding $15 million.

Plans to scale operations and enhance market presence, particularly in food safety and healthcare sectors, are underway.

4Bad News, Challenges, or Points of Concern

Revenue Decline: The year-over-year revenue drop of 24% raises concerns about customer reliance and market conditions.

Operating Loss: The shift from operating income to loss indicates potential challenges in managing costs while scaling operations.

Customer Dependency: The decline in sales from a key customer due to operational reorganization highlights vulnerability to customer-specific issues.

Market Awareness: There is a need for increased education and marketing efforts to inform potential customers about new FDA regulations and TOMI's offerings.

5Notable Q&A Insights

FDA Approval Impact: Management acknowledged the recent FDA approval as a potential game changer for entering the food industry but noted that many companies are still unaware of the change.

Sales Strategy: Increased focus on existing customer relationships and targeted marketing efforts to drive awareness and adoption of SteraMist technology.

International Expansion: Discussions regarding international sales efforts, particularly in Morocco and other regions, are ongoing, with a reliance on local distributors.

Military and Defense Markets: Positive developments in servicing military clients were mentioned, with expectations for significant contracts in 2026.

Growth in Solution Sales: Management expressed optimism about future solution sales, driven by increased capital equipment sales and improved customer engagement strategies. Overall, TOMI Environmental Solutions is navigating a challenging financial landscape while positioning itself for future growth through strategic initiatives and market expansion.